This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Ziad Nasreddine | |
|---|---|
| Name | Ziad Nasreddine |
| Birth place | Beirut, Lebanon |
| Occupation | Neurologist, Cognitive Researcher |
| Known for | Montreal Cognitive Assessment (MoCA) |
| Alma mater | American University of Beirut, McGill University |
Ziad Nasreddine is a Lebanese-Canadian neurologist and clinical researcher best known for creating the Montreal Cognitive Assessment (MoCA), a brief cognitive screening tool used internationally for detecting mild cognitive impairment and early dementia. He trained in Beirut and Montreal and has published on neuropsychological screening, Alzheimer's disease, Parkinson's disease, vascular dementia, and cognitive impairment related to stroke and traumatic brain injury. His work intersects with institutions and figures in neurology, geriatrics, and neuropsychology across North America and Europe.
Born in Beirut, Nasreddine completed undergraduate and medical studies at the American University of Beirut before emigrating to Canada for post-graduate training at McGill University and affiliated hospitals in Montreal. He undertook residency and fellowship training in neurology, interacting with departments linked to Université de Montréal, Montreal Neurological Institute and Hospital, and clinicians associated with McGill University Health Centre. During this period he collaborated informally with researchers engaged in studies at centers such as the Alzheimer's Disease Research Center and memory clinics influenced by work from A. R. Luria, Brenda Milner, and contemporaries in cognitive neurology.
Nasreddine's clinical appointments linked him to memory clinics and neurology services that evaluated patients referred from geriatricians and psychiatrists, often cross-referencing assessments rooted in instruments developed by Marshall F. Folstein, David Wechsler, and teams responsible for the Mini-Mental State Examination. His research output engaged with topics addressed by investigators at organizations like the World Health Organization, Alzheimer's Association, Canadian Institutes of Health Research, and academic groups studying biomarkers highlighted by consortia such as the Alzheimer's Disease Neuroimaging Initiative. He published papers and presented at meetings organized by entities including the American Academy of Neurology, International Psychogeriatric Association, and European Federation of Neurological Societies, situating his work amid parallel efforts by researchers such as Paul Aisen, Reisa Sperling, and Dennis J. Selkoe.
Seeking a brief, sensitive screening tool, Nasreddine developed the Montreal Cognitive Assessment in collaboration with clinicians and neuropsychologists influenced by measures like the Mini-Mental State Examination and tests from the Wechsler Adult Intelligence Scale and Cambridge Cognition. The MoCA was designed and validated with reference samples from memory clinics and studies influenced by cohorts used in research at the Mayo Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital. Initial validation compared cognitive profiles described in literature by researchers such as Alberto A. Fernández, Kenneth Rockwood, and Ronald C. Petersen, and incorporated tasks reflecting domains emphasized in work by Timothy R. Elliott and others studying executive function. The instrument underwent psychometric analysis following standards propagated by organizations like the International Test Commission and was disseminated through networks including the Canadian Stroke Network and academic centers influenced by McGill and Université de Montréal researchers.
The MoCA achieved rapid adoption across memory clinics, primary care settings, and research protocols in institutions such as the National Health Service clinics in the United Kingdom, the Veterans Health Administration in the United States, and hospitals affiliated with the University of Toronto, Harvard Medical School, and University College London. It has been translated and cross-culturally validated in studies coordinated with groups at the World Health Organization, European Alzheimer’s Disease Consortium, and regional research centers in Japan, China, Spain, and Brazil. Clinical guidelines from organizations including the Alzheimer's Association, Canadian Medical Association, and various national neurology societies have referenced MoCA data in protocols for screening cognitive impairment, echoing comparative evaluations seen in meta-analyses by teams associated with the Cochrane Collaboration and systematic reviews published in journals influenced by editors from The Lancet Neurology and JAMA Neurology.
Nasreddine's contributions have been recognized in forums sponsored by academic institutions and professional societies such as the Canadian Neurological Sciences Federation, the American Academy of Neurology, and regional chapters of the International Neuropsychological Society. His work on the MoCA has been cited in policy documents and guideline committees convened by organizations like the Alzheimer Society of Canada and the Canadian Stroke Consortium, and has been acknowledged in academic symposia honoring advances in cognitive screening led by figures from McGill University, University of British Columbia, and University of Alberta.
Nasreddine has maintained clinical practice and engagement with memory clinics and continues to be cited in research networks involving collaborators across institutions such as McGill University Health Centre, Montreal Neurological Institute and Hospital, Harvard Medical School, and the University of California, San Francisco. His legacy is tied to the widespread use of the MoCA in clinical assessment pathways shaped by international bodies and research consortia, influencing training programs at universities including McGill, University of Toronto, King's College London, and University College London.
Category:Lebanese physicians Category:Canadian neurologists Category:Medical researchers